These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The use of monoclonal antibody immunoconjugates in cancer therapy. Pietersz GA; Krauer K; McKenzie IF Adv Exp Med Biol; 1994; 353():169-79. PubMed ID: 7985535 [No Abstract] [Full Text] [Related]
6. Eighth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer. Introduction. Goldenberg DM Cancer; 2002 Feb; 94(4 Suppl):1193-5. PubMed ID: 11877744 [No Abstract] [Full Text] [Related]
7. Use of monoclonal antibodies for the diagnosis and treatment of bladder cancer. Syrigos KN; Deonarian DP; Epenetos AA Hybridoma; 1999 Jun; 18(3):219-24. PubMed ID: 10475235 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies in tumor therapy. Matzku S Recent Results Cancer Res; 1996; 141():1-8. PubMed ID: 8722416 [No Abstract] [Full Text] [Related]
9. Breast mucin and associated antigens in diagnosis and therapy. Peterson JA; Ceriani RL Adv Exp Med Biol; 1994; 353():1-8. PubMed ID: 7527177 [No Abstract] [Full Text] [Related]
10. Monoclonal antibody therapy of cancer. Jurcic JG; Scheinberg DA; Houghton AN Cancer Chemother Biol Response Modif; 1997; 17():195-216. PubMed ID: 9551215 [No Abstract] [Full Text] [Related]
11. [Monoclonal antibodies for diagnosis and therapy in oncological patients]. Boven E; Haisma HJ; Pinedo HM Ned Tijdschr Geneeskd; 1995 Dec; 139(49):2552-8. PubMed ID: 8657317 [No Abstract] [Full Text] [Related]
12. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma. Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754 [TBL] [Abstract][Full Text] [Related]
13. The 10th International Conference on Monoclonal Antibody Immunoconjugates for Cancer: Radiodosimetry and Radiopharmaceuticals for Therapy. Breitz H; Mills G; Siegel J; Stabin M; Wessels BW Cancer Biother Radiopharm; 1996 Feb; 11(1):25-42. PubMed ID: 10851518 [No Abstract] [Full Text] [Related]
14. Genetically engineered monoclonal antibodies armed with radionuclides. Waldmann TA Year Immunol; 1993; 7():205-12. PubMed ID: 8103951 [No Abstract] [Full Text] [Related]
15. Potential and limitations of radioimmunodetection and radioimmunotherapy with monoclonal antibodies. Zhu H; Baxter LT; Jain RK J Nucl Med; 1997 May; 38(5):731-41. PubMed ID: 9170438 [TBL] [Abstract][Full Text] [Related]
16. Advances in monoclonal antibody therapy of cancer. LoBuglio AF; Saleh MN Am J Med Sci; 1992 Sep; 304(3):214-24. PubMed ID: 1476160 [TBL] [Abstract][Full Text] [Related]
17. BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy. Parisi A; Bartolazzi A; Bonino C; Camagna M; DeMonte LB; Lombardi A; Natali PG; Paganelli G; Tarditi L; Vassarotto C Year Immunol; 1993; 7():96-105. PubMed ID: 8372516 [No Abstract] [Full Text] [Related]
18. [Radiolabeled antibodies for cancer treatment]. Barbet J; Chatal JF; Kraeber-Bodéré F Med Sci (Paris); 2009 Dec; 25(12):1039-45. PubMed ID: 20035676 [TBL] [Abstract][Full Text] [Related]
19. New insights into the pretargeting approach to image and treat tumours. Patra M; Zarschler K; Pietzsch HJ; Stephan H; Gasser G Chem Soc Rev; 2016 Nov; 45(23):6415-6431. PubMed ID: 27722526 [TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha-2b immunoconjugate for improving immunoscintigraphy and immunotherapy. Pallela VR; Rao SP; Thakur ML J Nucl Med; 2000 Jun; 41(6):1108-13. PubMed ID: 10855643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]